Arbutus Biopharma Corp. (ABUS)
4.48
-0.04
(-0.88%)
USD |
NASDAQ |
Apr 02, 16:00
4.49
+0.01
(+0.22%)
After-Hours: 20:00
Arbutus Biopharma Accounts Receivable (Annual) : 1.447M for Dec. 31, 2025
Accounts Receivable (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Annual) Benchmarks
| Moderna, Inc. | 184.00M |
| Merck & Co., Inc. | 11.78B |
| Pfizer Inc. | 11.87B |
| ACADIA Pharmaceuticals, Inc. | 121.46M |
| Alnylam Pharmaceuticals, Inc. | 777.57M |